Wednesday, November 18, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval

Kennethcix by Kennethcix
July 4, 2026
in Mergers & Acquisitions, Nasdaq, Tech & Software, Trading & Momentum
0
Realbotix Stock
0
SHARES
94
VIEWS
Share on FacebookShare on Twitter

Realbotix is navigating one of the most volatile stretches in its short public history as it pursues a high-stakes reverse takeover of Onconetix (NASDAQ: ONCO). The goal: list its wholly owned subsidiary, Realbotix LLC, on the Nasdaq Capital Market. But the path is anything but smooth, with supply chain bottlenecks, a recent revenue decline, and a share price that swings wildly on every piece of news.

The stock closed the week at €0.21, down 6.14% on Friday, yet still up 25.88% over the past seven trading sessions. That bounce masks a year‑to‑date loss of roughly 24% and a 30‑day annualized volatility of 88.09% — an extreme reading that underscores how heavily the market is betting on the Nasdaq outcome. From the October 2025 high of €0.39, the share remains 44.42% below that peak.

The Funding Engine: A Debt‑Free Balance Sheet

One of the few clear positives is the company’s financial position. Realbotix has eliminated all debt and now carries a “super clean” balance sheet, according to management, with more than twelve months of operating capital. This liquidity provides a cushion while the reverse merger is completed, insulating the stock from short‑term financing risks.

The deal structure gives Realbotix significant upside: after the transaction, the parent company will retain a 75% to 90% stake in the Nasdaq‑listed entity. CEO Andrew Kiguel has framed the move as a value unlock, not a dilution event, arguing that the ONCO capital will provide non‑dilutive financing for growth. “After the Nasdaq listing there will be a clearer, more visible market value for the commercial robotics business — and better access to capital, institutional investors and long‑term growth opportunities,” he said.

Operational Reality: Thin Revenue, Delayed Deliveries

The near‑term business remains lean. In the second quarter of 2026 (Q2 2026), Realbotix reported revenue of only $225,000, down sharply from the prior year as it deliberately wound down its crypto operations to focus on humanoid robotics. Net income came in at $442,000, but that figure was driven by one‑time items rather than core operations. Management acknowledges that immediate revenue growth is limited and that the near‑term focus is on development.

A more structural challenge is the supply chain. Realbotix has been unable to secure enough Nvidia Thor processors, a critical component for its humanoid robots. The shortage is not a temporary hiccup; it is an ongoing constraint that threatens to delay commercial shipments just as the company tries to build momentum. On the production side, Realbotix has moved into a larger facility near Las Vegas to improve assembly capacity and streamline workflows, but without chips, higher volumes remain aspirational.

Should investors sell immediately? Or is it worth buying Realbotix?

Commercial Milestones and the Ambitious Target

Despite the headwinds, Realbotix has begun delivering real systems. In April it shipped initial units to telecom giant Ericsson, and in late June it entered the education sector with a U.S. school district deploying humanoid robots and AI assistants. These reference customers are important proof points, but they have not yet translated into meaningful recurring revenue.

The company’s long‑term target is ambitious: $100 million in quarterly revenue from AI and robotics within three to four years. For now, the entire business is valued at roughly $55 million — a fraction of the multi‑billion‑dollar valuations carried by some comparable robotics firms. That discount reflects the market’s skepticism about execution, not just size.

Chart Levels and Key Catalysts

Technically, the stock is testing important thresholds. The 200‑day moving average at €0.22 acts as resistance, currently just 4.67% above the closing price. Support sits at the 50‑day trendline, while the Relative Strength Index has cooled to 60, unwinding the overbought condition from earlier in the week. The 52‑week low of €0.15, set on June 29, 2026, remains a potential retest if the merger or supply chain falters.

The most immediate catalyst is the timeline for the Onconetix reverse takeover. The definitive agreement sets a deadline of October 31, 2026, for completion, but the deal still requires approval from both Onconetix shareholders and the TSX Venture Exchange. Any delay beyond that window would remove the Nasdaq premium that optimistic investors have already priced in.

Separately, the company is expected to provide an update on robot delivery timelines. As of early July 2026, neither the shareholder vote nor a clear resolution on the Nvidia chip shortage had been announced. Until those boxes are checked, Realbotix remains a high‑volatility bet on a single binary outcome.

Ad

Realbotix Stock: Buy or Sell?! New Realbotix Analysis from November 18 delivers the answer:

The latest Realbotix figures speak for themselves: Urgent action needed for Realbotix investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 18.

Realbotix: Buy or sell? Read more here...

Tags: Realbotix
Kennethcix

Kennethcix

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Next Post
Intuit Stock

Intuit's Valuation Discount Is Tempting — But Lawsuits and a DIY Price War Keep Buyers at Bay

Mercedes-Benz Stock

Mercedes-Benz Stock Mounts Comeback as Labor Dispute Escalates Over Soured Bonus Payments

SpaceX Stock

Starbase Static Fire Clears Path for Next Starship Test as SpaceX Stock Hovers at a Crossroads

Recommended

aTyr Pharma Stock

Make or Break Moment Approaches for aTyr Pharma

1 year ago
Battalion Oil Stock

Battalion Oil: Record-Breaking Wells in the Permian, But a Shelf Filing Casts a Long Shadow

7 months ago
IonQ Stock

IonQ Posts 755% Q1 Revenue Jump as Quantum Security Product Hits the Market

5 months ago
Stryker Stock

Analyst Confidence and Insider Activity Signal Strength for Stryker

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

At 5.15%, the 10-Year Treasury Picks the Winners

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

The AI Rebound Gets an Audit: Who Earns, Who Borrows

A Hot CPI Reading Stalls the Rebound and Puts a December Hike in Play

Cash Over Stories: Take-Two, Cisco and Nvidia Face Their Tests

Trending

Nvidia Stock
Newsletter

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

by Stephanie Dugan
November 18, 2026
0

Dear readers, Nvidia reported the best quarter in its history, according to the company, and the founder...

Home Depot Stock

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

November 17, 2026
Bitcoin Stock

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

November 16, 2026
Cisco Stock

At 5.15%, the 10-Year Treasury Picks the Winners

November 14, 2026
Bitcoin Stock

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

November 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone
  • Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers
  • Rotation, Not Panic: Retailers Test Where Tech’s Money Went

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com